Results
8703
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,703 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
6181 | HK$208.00 | -12.1% | n/a | HK$35.0b | HK$228.12 | PE40.7x | E34.2% | n/a | Consumer Durables | ||
YGG | ฿0.52 | -14.8% | -92.7% | ฿313.0m | ฿10.75 | PS1.5x | E87.1% | 51.5% | Media | ||
9992 | HK$94.35 | 1.5% | 389.9% | HK$125.1b | HK$91.37 | PE76.9x | E35.3% | 0.3% | Retail | ||
AVL | ₹528.15 | 8.1% | n/a | ₹68.0b | ₹560.75 | PE71.3x | E26.7% | 0.2% | Retail | ||
ACI | ₹655.35 | -2.1% | 1.0% | ₹80.9b | ₹826.00 | PE36.8x | E41.3% | 0.5% | Materials | ||
MBTN | CHF 2.41 | 21.4% | -98.3% | CHF 74.5m | CHF 6.03 | PS0.9x | E109.3% | n/a | Semiconductors | ||
TGTX | US$32.20 | -6.4% | 89.4% | US$4.6b | US$40.75 | PS17.5x | E57.0% | n/a | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.33 | -5.2% | 50.9% | ج.م28.4b | ج.م11.67 | PE22.9x | E27.4% | n/a | Diversified Financials | ||
RMDA | ج.م3.41 | -2.6% | 109.6% | ج.م5.1b | ج.م5.02 | PE19.3x | E30.7% | 2.0% | Pharmaceuticals & Biotech | ||
DOMS | ₹2,781.00 | -6.6% | 112.8% | ₹168.8b | ₹3,052.00 | PE90.9x | E23.2% | 0.09% | Commercial Services | ||
SFPTECH | RM 0.70 | -0.7% | -25.4% | RM 1.7b | RM 0.96 | PE44.1x | E28.3% | 0.6% | Capital Goods | ||
ZVRA | US$8.49 | 0.6% | 70.8% | US$453.2m | US$20.00 | PS18.5x | E73.5% | n/a | Pharmaceuticals & Biotech | ||
ICOP | €8.32 | 0.2% | n/a | €229.9m | €9.80 | PE45.5x | E49.2% | n/a | Capital Goods | ||
RHM | €611.60 | -2.0% | 114.8% | €26.6b | €721.93 | PE38.8x | E29.9% | 0.9% | Capital Goods | ||
WAYS | SEK 15.72 | -2.7% | -46.4% | SEK 126.9m | SEK 36.50 | PS1x | E113.3% | 0% | Tech | ||
PRL | CA$36.03 | -2.9% | 179.5% | CA$1.4b | CA$44.28 | PE22.4x | E37.6% | 1.7% | Diversified Financials | ||
ELABS | NOK 10.38 | -1.1% | -41.9% | NOK 1.1b | NOK 22.00 | PS11.7x | E111.4% | n/a | Software | ||
ARES | US$176.04 | -4.2% | 52.0% | US$55.1b | US$185.31 | PE82.2x | E38.4% | 2.1% | Diversified Financials | ||
CADLR | NOK 63.60 | -0.9% | 35.6% | NOK 22.3b | NOK 82.90 | PE207x | E70.4% | n/a | Capital Goods | ||
TVTX | US$17.18 | -1.8% | 89.6% | US$1.5b | US$27.40 | PS7.3x | E72.5% | n/a | Pharmaceuticals & Biotech | ||
PHM | €78.50 | -0.5% | 83.2% | €1.4b | €83.20 | PE2213.5x | E56.2% | 0.8% | Pharmaceuticals & Biotech | ||
AGP | €6.30 | -4.0% | 4.7% | €109.1m | €12.85 | PE16.1x | E22.1% | n/a | Capital Goods | ||
SKS | AU$1.59 | -19.1% | 476.4% | AU$177.6m | AU$2.15 | PE26.8x | E24.8% | 0.6% | Capital Goods | ||
5038 | JP¥2,008.00 | 9.4% | 3.9% | JP¥28.7b | n/a | PE42.1x | E28.7% | 0.5% | Healthcare |